CRL insider trading
HealthcareCHARLES RIVER LABORATORIES INTERNATIONAL, INC. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company has strategic collaborations with Parker Institute for Cancer Immunotherapy and Children's Hospital Los Angeles across its contract development and manufacturing organization. Additionally, It has a strategic alliance with Francis Crick Institute (Crick), Inc. for the development of Antibody-Drug Conjugate (ADC) drug discovery and development. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
Company website: www.criver.com
CRL insider activity at a glance
FilingIQ has scored 4,662 insider transactions for CRL since Jan 8, 2015. The most recent filing in our index is dated May 12, 2026.
Across the full history, 10 open-market purchases
and 3,714 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on CRL insider trades is 56.0/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest CRL Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
13F funds holding CRL
Frequently asked
- How many insider trades does FilingIQ track for CRL?
- FilingIQ tracks 4,662 Form 4 insider transactions for CRL (CHARLES RIVER LABORATORIES INTERNATIONAL, INC.), covering filings from Jan 8, 2015 onwards. 21 of those were filed in the last 90 days.
- Are CRL insiders net buyers or net sellers?
- Across the full Form 4 history for CRL, 10 transactions (0%) were open-market purchases and 3,714 (80%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does CRL insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is CRL in?
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) is classified in the Healthcare sector, specifically Diagnostics & Research, with a current market capitalisation of $7.94B.
Methodology & sources
Every CRL insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.